✦ LIBER ✦

Novel, Achiral 1,3,4-Benzotriazepine Analogues of 1,4-Benzodiazepine-Based CCK 2 Antagonists That Display High Selectivity over CCK 1 Receptors

✍ Scribed by McDonald, Iain M.; Austin, Carol; Buck, Ildiko M.; Dunstone, David J.; Griffin, Eric; Harper, Elaine A.; Hull, Robert A. D.; Kalindjian, S. Barret; Linney, Ian D.; Low, Caroline M. R.; Pether, Michael J.; Spencer, John; Wright, Paul T.; Adatia, Trushar; Bashall, Alan

Book ID: 127100418
Publisher: American Chemical Society
Year: 2006
Tongue: English
Weight: 150 KB
Volume: 49
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm051219x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3D QSAR studies of 1,3,4-benzotriazepine

3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists

✍ Kirandeep Kaur; Tanaji T. Talele 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 734 KB

Optimization of 1,3,4-Benzotriazepine-Ba

Optimization of 1,3,4-Benzotriazepine-Based CCK 2 Antagonists to Obtain Potent, Orally Active Inhibitors of Gastrin-Mediated Gastric Acid Secretion

✍ McDonald, Iain M.; Black, James W.; Buck, Ildiko M.; Dunstone, David J.; Griffin 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 322 KB

Synthesis of N-(2,3-dihydro-1-[14C]methy

Synthesis of N-(2,3-dihydro-1-[14C]methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-benzamide and N-(2,3-dihydro-1-[14C]methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N-[14C]methyl-benzamide as novel carbon-14 labelled CCK antagonists

✍ Hojatollah Matloubi; Ali Khalaj; Reza Dowlatabadi; Gholamhossein Shirvani 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB 👁 1 views

## Abstract Two benzodiazepine CCK antagonists __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H 1,4‐benzodiazepin‐3‐yl)‐benzamide **2** and __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H‐1,4‐benzodiazepin‐3‐yl)‐[^14^C]methyl‐benzamide **3** were synthesized in high yields through the reac

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-tr

3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4- a ]phthalazines and Analogues: High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1

✍ Carling, Robert W.; Moore, Kevin W.; Street, Leslie J.; Wild, Deborah; Isted, Ca 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 254 KB